Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
Latin American market in 2020 and is expected to maintain its position during the forecast period. The current standard of treatment of GBM in Brazil is the same as surgery, followed by radiation and temozolomide. A research article has investigated 113 patients in the country with GBM to evaluate their suitability for the novel targeted therapies.
Patients were evaluated for tumor genomic characteristics including ROS1 & NTRK1 rearrangements; PDGFRA, KIT, & KDR amplification; and RB1 deletion and clinical features. Patients’ survival ratio remains intact independent of the molecular abnormalities.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil glioblastoma multiforme treatment market , including forecasts for subscribers. This country databook contains high-level insights into Brazil glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account